Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Silymarin: a review of its clinical properties in the management of hepatic disorders.

Wellington K, Jarvis B.

BioDrugs. 2001;15(7):465-89. Review.

PMID:
11520257
2.

Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.

Pradhan SC, Girish C.

Indian J Med Res. 2006 Nov;124(5):491-504. Review.

PMID:
17213517
3.

The use of silymarin in the treatment of liver diseases.

Saller R, Meier R, Brignoli R.

Drugs. 2001;61(14):2035-63. Review.

PMID:
11735632
4.

[Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].

Pár A, Róth E, Rumi G Jr, Kovács Z, Nemes J, Mózsik G.

Orv Hetil. 2000 Jul 23;141(30):1655-9. Hungarian.

PMID:
10962902
5.

Milk thistle in liver diseases: past, present, future.

Abenavoli L, Capasso R, Milic N, Capasso F.

Phytother Res. 2010 Oct;24(10):1423-32. doi: 10.1002/ptr.3207. Review.

PMID:
20564545
6.

[Silibinin and its hepatoprotective action from the perspective of a toxicologist].

Kostek H, Szponar J, Tchórz M, Majewska M, Lewandowska-Stanek H.

Przegl Lek. 2012;69(8):541-3. Review. Polish.

PMID:
23243923
7.

An updated systematic review with meta-analysis for the clinical evidence of silymarin.

Saller R, Brignoli R, Melzer J, Meier R.

Forsch Komplementmed. 2008 Feb;15(1):9-20. doi: 10.1159/000113648. Review.

PMID:
18334810
8.

[Pharmacotherapy of Amanita phalloides poisoning using silybin].

Hruby K, Fuhrmann M, Csomos G, Thaler H.

Wien Klin Wochenschr. 1983 Apr 1;95(7):225-31. German.

PMID:
6410590
9.

[Drug clinics. Drug of the month. Legalon (silymarin)].

Luyckx F, Scheen AJ.

Rev Med Liege. 1997 Dec;52(12):792-6. French. No abstract available.

PMID:
9481179
10.

Silymarin in the prevention and treatment of liver diseases and primary liver cancer.

Féher J, Lengyel G.

Curr Pharm Biotechnol. 2012 Jan;13(1):210-7. Review.

PMID:
21466434
11.

A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis.

El-Kamary SS, Shardell MD, Abdel-Hamid M, Ismail S, El-Ateek M, Metwally M, Mikhail N, Hashem M, Mousa A, Aboul-Fotouh A, El-Kassas M, Esmat G, Strickland GT.

Phytomedicine. 2009 May;16(5):391-400. doi: 10.1016/j.phymed.2009.02.002. Epub 2009 Mar 19.

12.

Milk thistle.

Rainone F.

Am Fam Physician. 2005 Oct 1;72(7):1285-8. Review.

13.

Therapeutic efficacy of silymarin and naringenin in reducing arsenic-induced hepatic damage in young rats.

Jain A, Yadav A, Bozhkov AI, Padalko VI, Flora SJ.

Ecotoxicol Environ Saf. 2011 May;74(4):607-14. doi: 10.1016/j.ecoenv.2010.08.002. Epub 2010 Aug 17.

PMID:
20719385
14.

Effect of silybin on high-fat-induced fatty liver in rats.

Yao J, Zhi M, Minhu C.

Braz J Med Biol Res. 2011 Jul;44(7):652-9. Epub 2011 Jul 8.

15.

[Silymarin in the treatment of chronic liver diseases: past and future].

Fehér J, Lengyel G.

Orv Hetil. 2008 Dec 21;149(51):2413-8. doi: 10.1556/OH.2008.28519. Review. Hungarian.

PMID:
19073452
16.

[Treatment of Amanita phalloides poisoning with silybin in combination with penicillin and cortisone].

Hofer JF, Egermann G, Mach K, Sommer K.

Wien Klin Wochenschr. 1983 Apr 1;95(7):240-3. German.

PMID:
6880207
17.

Free radical reactions might contribute to severe alpha amanitin hepatotoxicity--a hypothesis.

Zheleva A, Tolekova A, Zhelev M, Uzunova V, Platikanova M, Gadzheva V.

Med Hypotheses. 2007;69(2):361-7. Epub 2007 Mar 2.

PMID:
17336461
18.

[Acute hepatic failure after ingestion of mushrooms].

Oeckinghaus R, Cuneo A, Brockmeier J, Oeckinghaus GS, Drewek-Platena S, Hochreuther S, Götz J, Tebbe U.

Internist (Berl). 2012 May;53(5):619-24. doi: 10.1007/s00108-011-3008-z. German.

PMID:
22527661
19.

Oxidative stress in the liver and biliary tract diseases.

Fehér J, Lengyel G, Blázovics A.

Scand J Gastroenterol Suppl. 1998;228:38-46. Review.

PMID:
9867111
20.

[Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol)].

Müzes G, Deák G, Láng I, Nékám K, Niederland V, Fehér J.

Orv Hetil. 1990 Apr 22;131(16):863-6. Hungarian.

PMID:
2345633
Items per page

Supplemental Content

Write to the Help Desk